Vinícius Queiroz Oliveira, Luísa Carregosa Santos, Samuel Cota Teixeira, Thiago Macedo Lopes Correia, Leonardo Oliveira Silva Bastos Andrade, Sarah Natalie Cirilo Gimenes, Mônica Colombini, Lucas Miranda Marques, Eliécer Jiménez-Charris, Luciana Aparecida Freitas-de-Sousa, Marcelo José Barbosa Silva, Amélia Cristina Mendes de Magalhães Gusmão, Eloisa Amália Vieira Ferro, Patricia Bianca Clissa, Veridiana de Melo Rodrigues, Daiana Silva Lopes
Angiogenesis is a process that is controlled by a delicate combination of proangiogenic and antiangiogenic molecules and can be disrupted in various illnesses, including cancer. Non-cancerous diseases can also have an abnormal or insufficient vascular growth, inflammation and hypoxia, which exacerbate angiogenesis. These conditions include atherosclerosis, psoriasis, endometriosis, asthma, obesity and AIDS. Based on that, the present work assessed the in vitro and ex vivo antiangiogenic properties stemming from BthMP, a P-I metalloproteinase from Bothrops moojeni snake venom, via the VEGF pathway...
March 5, 2024: Biochemical and Biophysical Research Communications